Next Article in Journal
Orphan GPR26 Counteracts Early Phases of Hyperglycemia-Mediated Monocyte Activation and Is Suppressed in Diabetic Patients
Next Article in Special Issue
Adalimumab Biosimilar GP2017 versus Adalimumab Originator in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study
Previous Article in Journal
Editorial for the Specific Issue: “Lipid-Based Nanocarriers”
Previous Article in Special Issue
Health Benefits of Dietary Fiber for the Management of Inflammatory Bowel Disease
 
 
Review

Article Versions Notes

Biomedicines 2022, 10(7), 1735; https://doi.org/10.3390/biomedicines10071735
Action Date Notes Link
article xml file uploaded 19 July 2022 09:24 CEST Original file -
article xml uploaded. 19 July 2022 09:24 CEST Update https://www.mdpi.com/2227-9059/10/7/1735/xml
article pdf uploaded. 19 July 2022 09:24 CEST Version of Record https://www.mdpi.com/2227-9059/10/7/1735/pdf
article html file updated 19 July 2022 09:36 CEST Original file -
article html file updated 13 August 2022 02:27 CEST Update https://www.mdpi.com/2227-9059/10/7/1735/html
Back to TopTop